Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hearticellgram-AMI in Acute Myocardial Infarction
NCT01652209Phase 3Completed
- Sponsor
- Pharmicell Co., Ltd.
- Start
- Sep 2013
- Primary completion
- Aug 2024
- Modality
- Mesenchymal Stem Cells
- Countries
- 1
01
Overview
A Phase 3 trial of Hearticellgram-AMI in acute myocardial infarction (AMI), sponsored by Pharmicell Co., Ltd.. Started Sep 2013; status: completed.
02
Drugs
Hearticellgram-AMI
03
Conditions
acute myocardial infarction (AMI)
Beyond the preview
Go deeper on NCT01652209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01652209.